EDMONTON, Alberta--(BUSINESS WIRE)--Nov. 3, 2005--ViRexx Medical Corp. (TSX:VIR), a company focused on immunotherapy treatments for cancer, chronic hepatitis B & C and embolotherapy treatments for tumors today announced that Marc Canton, President and Chief Operating Officer of ViRexx, is scheduled to present at the upcoming Rodman & Renshaw Techvest Seventh Annual Healthcare Conference. The presentation is scheduled for 10:10 a.m. (Eastern Time) on Monday, November 7, 2005. The event will be held from November 7-9, 2005 at the New York Palace Hotel in New York.
